Mustafa Gundogdu

Mustafa Gundogdu

Auto-generated profile, based on publicly available information

Mustafa Gundogdu

Dermatology and Venereology Outpatient Clinic Ordu State Hospital Ordu Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2019 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
SVSeçil Vural
Seçil Vural
MGMustafa Gündoğdu
Mustafa Gündoğdu
BABengu Nisa Nisa Akay
Bengu Nisa Nisa Akay
ABAyşe Boyvat
Ayşe Boyvat
CECengizhan Erdem
Cengizhan Erdem
NKNihal Kundakci
Nihal Kundakci

8 March 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
GDGöktürk Dere
Göktürk Dere
MGMustafa Gündoğdu
Mustafa Gündoğdu

21 November 2020 in Dermatologic Therapy
Verified
Journal Article
Closed access
PDF file
MGMustafa Gündoğdu
Mustafa Gündoğdu
NENihan Erden
Nihan Erden
EKEbru Karagun
Ebru Karagun
AAAyşe Şermin Filiz Acıpayam
Ayşe Şermin Filiz Acıpayam
SVSeçil Vural
Seçil Vural

8 March 2021 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
MGMustafa Gundogdu
Mustafa Gundogdu
GDGokturk Dere
Gokturk Dere
Aim: To investigate whether acne treatment agent systemic isotretinoin causes susceptibility to COVID‐19 disease.Material and method: Patients admitted to a single center due to acne between March 2020 and December 2020 were included. A retrospective analysis was conducted on the medical records of acne patients receiving systemic isotretinoin or topical treatments. The patients with PCR‐confirmed SARS‐CoV‐2 infection were recorded.Results: 302 patients who used isotretinoin and 329 patients who used topical treatment were included in the study. No statistically significant difference was found between the groups in terms of age (p = 0.151). It was found that of the 302 patients who used isotretinoin, 33 had PCR test for SARS‐CoV‐2 and two of these had PCR positivity, while of the 329 patients who received topical treatment, 45 had PCR test and five of these had PCR positivity. No statistically significant difference was found between the groups in terms of having SARS‐CoV‐2 positivity with PCR (p = 0.692).Conclusion: Susceptibility to COVID‐19 disease was not observed in patients using systemic isotretinoin.

30 December 2021 in Rheumatology
Verified
Journal Article
Open access
AEAyşe Ünal Enginar
Ayşe Ünal Enginar
MGMustafa Gundogdu
Mustafa Gundogdu
Objectives To evaluate the frequency and clinical course of coronavirus disease 2019 (COVID-19) in patients with Behçet’s disease (BD). Material and methods The study included patients diagnosed with BD according to the International Study Group for BD criteria who were being followed up in...

5 February 2022 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
MGMustafa Gundogdu
Mustafa Gundogdu
ABAyşenur Botsalı
Ayşenur Botsalı
SVSeçil Vural
Seçil Vural